CD274 and neoplasm: A personalized systemic induction therapy plan was developed based on the results of comprehensive tumor landscape gene testing, circulating tumor DNA (ctDNA) testing, and programmed death-ligand 1 (PD-L1) testing (as shown in Tables 1-3).